Product Details
Product Name:
MC2184 |
CAS No.:
74901-20-5 |
Supply Ability:
10g |
Release date:
2025/04/27 |
Product Introduction
Bioactivity
Name | MC2184 |
Description | MC2184 is the inhibitor of human recombinant SIRT1. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 10 mg/mL (46.69 mM), Sonication is recommended.
|
Keywords | SIRT1 | MC-2184 | MC2184 | MC 2184 |
Inhibitors Related | JGB1741 | Sirtinol | Selisistat | Dihydrocoumarin | Nicotinamide riboside chloride | Resveratrol | SRT 2104 | Nicotinamide riboside | MC3482 | Fisetin | 3-TYP | Nicotinamide |
Related Compound Libraries | Histone Modification Compound Library | DNA Damage & Repair Compound Library | Bioactive Compound Library | Endoplasmic Reticulum Stress Compound Library | Epigenetics Compound Library | Glutamine Metabolism Compound Library | Inhibitor Library | Mitochondria-Targeted Compound Library | NO PAINS Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:688353-45-9
$78.00 / 1mg
-
CAS:1483-07-4
$39.00 / 5mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |